+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
MRI Guided Neurosurgical Ablation Market - Global Forecast 2026-2032- Product Image
MRI Guided Neurosurgical Ablation Market - Global Forecast 2026-2032- Product Image
Sale

MRI Guided Neurosurgical Ablation Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968798
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The MRI Guided Neurosurgical Ablation Market is projected to reach USD 785.53 Million in 2026. It is expected to continue growing at a CAGR of 8.29%, reaching USD 1.26 Billion by 2032.

MRI guided neurosurgical ablation is redefining functional neurosurgery, neuro-oncology, and epilepsy care by combining stereotactic targeting with real-time magnetic resonance imaging and thermal monitoring. The field includes laser interstitial thermal therapy, often called LITT, and MRI guided focused ultrasound, both of which enable precise lesioning while reducing the need for large craniotomies in selected patients.

Demand is anchored in measurable clinical need. The World Health Organization reports that epilepsy affects around 50 million people worldwide, Parkinson disease affected more than 8.5 million people in 2019, and GLOBOCAN 2022 recorded more than 300,000 new brain and central nervous system cancer cases globally. These disease burdens support sustained interest in minimally invasive neurosurgical ablation technologies that can improve procedural precision, recovery profiles, and care pathways for complex neurological conditions.

Transformative Shifts in the Neurosurgical Ablation Landscape

The landscape is shifting from exposure-heavy neurosurgery toward image-guided, incision-sparing intervention. MRI thermometry allows clinicians to visualize temperature changes during ablation, improving procedural control and supporting protection of eloquent brain structures. This capability is especially important in deep-seated lesions, drug-resistant epilepsy foci, tremor pathways, and movement disorder targets where millimetric accuracy is critical.

Adoption is also being shaped by higher-field MRI availability, stereotactic robotics, improved laser fiber and transducer designs, and hospital priorities around shorter recovery times. Payers and health systems are increasingly evaluating ablation through measurable outcomes such as seizure reduction, tremor control, length of stay, complication rates, neurocognitive preservation, and retreatment requirements.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence every phase of MRI guided neurosurgical ablation, from patient selection to treatment planning and post-procedure surveillance. AI-enabled segmentation can help identify lesion boundaries, vascular structures, white matter tracts, and thermal-risk zones, while predictive models may support trajectory planning, ablation-volume estimation, and follow-up imaging assessment.

The impact is cumulative rather than isolated. As the U.S. Food and Drug Administration list of AI and machine learning-enabled medical devices has expanded rapidly, with radiology representing the largest category, neurosurgical teams are gaining access to increasingly mature image-analysis tools. However, clinical adoption depends on validation, explainability, cybersecurity, workflow integration, and evidence that AI improves safety, reproducibility, or patient outcomes in MRI guided neurosurgical ablation.

Key Regional Insights Across Major Markets

North America remains a leading region for MRI guided neurosurgical ablation due to advanced hospital infrastructure, high MRI capacity, active academic neurosurgery programs, and established regulatory pathways for technologies such as LITT platforms and MRI guided focused ultrasound systems. The United States anchors regional adoption through specialized epilepsy, neuro-oncology, and movement disorder centers, while Canada supports evidence-based use within publicly funded care models.

Europe shows strong adoption potential through specialized neurosurgical centers, robust clinical research networks, and broad access to advanced neuroimaging; however, implementation is influenced by EU Medical Device Regulation requirements, reimbursement variability, and health technology assessment standards. Asia-Pacific is gaining momentum as Japan, China, South Korea, India, and Australia expand advanced imaging, oncology, epilepsy, and movement disorder programs, supported by rising investment in tertiary neuroscience infrastructure. Latin America is developing through private tertiary hospitals and major academic centers in Brazil and Mexico, although access remains uneven across public systems and rural populations. The Middle East, particularly high-income Gulf countries, is investing in high-acuity neuroscience infrastructure and medical travel retention, while Africa faces MRI access constraints that make regional centers of excellence essential for broader availability of MRI guided neurosurgical ablation.

Key Group Insights for Strategic Market Positioning

Across ASEAN, growth is supported by expanding private hospitals, medical tourism, and neurosurgical modernization in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines, although procedure availability depends on trained specialists, MRI capacity, and referral pathways. The GCC is positioned as a premium adoption cluster because national health strategies in Saudi Arabia, the United Arab Emirates, Qatar, and neighboring markets prioritize advanced tertiary care, neuroscience centers, and reduced outbound medical travel.

The European Union offers a large, highly regulated clinical environment with strong research networks, cross-border evidence generation, and centralized procurement in many health systems, while BRICS countries combine substantial neurological disease burden and large patient populations with uneven infrastructure and reimbursement maturity. G7 markets generally lead in clinical evidence generation, reimbursement assessment, regulatory oversight, and academic adoption of MRI guided neurosurgical ablation. NATO countries benefit from advanced hospital systems, technology interoperability, and established neuroscience research capacity, particularly where trauma, rehabilitation, and complex neurosurgical services strengthen broader neurological care ecosystems.

Key Country Insights in MRI Guided Neurosurgical Ablation

The United States leads commercialization through academic medical centers, private hospital systems, FDA-cleared platforms, and high procedural specialization across epilepsy surgery, neuro-oncology, and functional neurosurgery, while Canada emphasizes evidence-based adoption within publicly funded care. Mexico and Brazil show growing demand in major urban centers, particularly where private insurers, specialist hospitals, and tertiary academic institutions support advanced neurosurgical procedures.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine sophisticated neuroimaging, established neurosurgical training, and strong clinical research capacity, while Russia has selective adoption through major federal and urban centers with advanced imaging infrastructure. China is scaling advanced neurosurgery rapidly through large hospital networks and expanding MRI capacity, India has high unmet neurological need and expanding private-sector capability, Japan and South Korea benefit from technology-intensive healthcare systems and strong imaging infrastructure, and Australia supports adoption through specialized centers serving a geographically dispersed population with complex referral needs.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinical evidence that compares MRI guided neurosurgical ablation with open surgery, radiosurgery, deep brain stimulation, and medical management for well-defined indications. Evidence packages should include seizure outcomes, tremor scores, tumor control indicators where relevant, length of stay, neurocognitive outcomes, adverse events, patient-reported outcomes, and total cost of care.

Commercial strategy should focus on multidisciplinary centers that combine neurosurgery, neuroradiology, epilepsy monitoring, neuro-oncology, radiation oncology, and movement disorder expertise. Technology developers and service providers should also invest in physician training, MRI compatibility support, service uptime, reimbursement dossiers, AI validation, cybersecurity readiness, and patient-selection tools that help hospitals build safe, repeatable MRI guided neurosurgical ablation programs.

Research Methodology

This executive summary is developed using a structured secondary research approach. Inputs include peer-reviewed neurosurgery and neuroradiology literature, regulatory databases, publicly available device-clearance information, hospital adoption patterns, disease-burden data from the World Health Organization and GLOBOCAN, and policy context from regional health authorities.

Insights are triangulated across clinical evidence, technology readiness, reimbursement dynamics, regulatory context, and infrastructure indicators such as MRI availability and tertiary neurosurgery capacity. The methodology avoids unsupported market-size claims and emphasizes verified trends, documented disease burden, regulatory status, clinical-use patterns, and observable adoption drivers across regions, economic groups, and major countries.

Conclusion

MRI guided neurosurgical ablation is moving from specialized innovation to a strategic capability in advanced neuroscience care. Its value proposition is strongest where precise targeting, real-time thermal feedback, shorter recovery, and reduced surgical exposure align with clinical needs in epilepsy, brain tumors, and movement disorders.

Future progress will depend on evidence quality, reimbursement confidence, center-level expertise, MRI access, and integration with AI-enabled imaging workflows. Organizations that combine clinically validated technology, disciplined training, regional access strategies, and outcome-driven commercialization will be best positioned in the evolving MRI guided neurosurgical ablation landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. MRI Guided Neurosurgical Ablation Market, by Technology Type
7.1. Introduction
7.2. MRI-Guided Laser Ablation
7.3. MRI-Guided Radiofrequency (RF) Ablation
7.4. MRI-Guided Focused Ultrasound
8. MRI Guided Neurosurgical Ablation Market, by Procedure Type
8.1. Introduction
8.2. Minimally Invasive Procedures
8.3. Non-Invasive Procedures
9. MRI Guided Neurosurgical Ablation Market, by Procedure Objective
9.1. Introduction
9.2. Curative Procedures
9.3. Palliative Procedures
9.4. Functional Modulation Procedures
10. MRI Guided Neurosurgical Ablation Market, by Application
10.1. Introduction
10.2. Brain Tumors
10.2.1. Glioblastoma
10.2.2. Meningioma
10.2.3. Metastatic Tumors
10.3. Chronic Pain
10.3.1. Sciatica
10.3.2. Trigeminal Neuralgia
10.4. Epilepsy
10.4.1. Focal Epilepsy
10.4.2. Temporal Lobe Epilepsy
10.5. Movement Disorders
10.5.1. Dystonia
10.5.2. Essential Tremor
10.5.3. Parkinson’s Disease
11. MRI Guided Neurosurgical Ablation Market, by Region
11.1. Asia-Pacific
11.2. Europe
11.3. North America
11.4. Latin America
11.5. Africa
11.6. Middle East
12. MRI Guided Neurosurgical Ablation Market, by Group
12.1. NATO
12.2. G7
12.3. BRICS
12.4. European Union
12.5. ASEAN
12.6. GCC
13. MRI Guided Neurosurgical Ablation Market, by Country
13.1. China
13.2. United States
13.3. Japan
13.4. India
13.5. Germany
13.6. United Kingdom
13.7. Australia
13.8. France
13.9. South Korea
13.10. Italy
13.11. Canada
13.12. Russia
13.13. Brazil
13.14. Mexico
13.15. Spain
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
14.3.1. Concentration Ratio (CR)
14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Accuray Incorporated
15.2. AngioDynamics, Inc.
15.3. Boston Scientific Corporation
15.4. ClearPoint Neuro, Inc.
15.5. Elekta AB
15.6. Insightec Ltd.
15.7. Medtronic plc
15.8. Monteris Medical Inc.
15.9. Profound Medical Corp.
15.10. Siemens Healthineers AG
List of Figures
FIGURE 1. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL MRI-GUIDED LASER ABLATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL MRI-GUIDED LASER ABLATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL MRI-GUIDED LASER ABLATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL MRI-GUIDED RADIOFREQUENCY (RF) ABLATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL MRI-GUIDED RADIOFREQUENCY (RF) ABLATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL MRI-GUIDED RADIOFREQUENCY (RF) ABLATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL MRI-GUIDED FOCUSED ULTRASOUND MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL MRI-GUIDED FOCUSED ULTRASOUND MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL MRI-GUIDED FOCUSED ULTRASOUND MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL MINIMALLY INVASIVE PROCEDURES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL MINIMALLY INVASIVE PROCEDURES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL MINIMALLY INVASIVE PROCEDURES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL NON-INVASIVE PROCEDURES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL NON-INVASIVE PROCEDURES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL NON-INVASIVE PROCEDURES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL CURATIVE PROCEDURES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL CURATIVE PROCEDURES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL CURATIVE PROCEDURES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL PALLIATIVE PROCEDURES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL PALLIATIVE PROCEDURES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL PALLIATIVE PROCEDURES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL FUNCTIONAL MODULATION PROCEDURES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL FUNCTIONAL MODULATION PROCEDURES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL FUNCTIONAL MODULATION PROCEDURES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL BRAIN TUMORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL BRAIN TUMORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL BRAIN TUMORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL GLIOBLASTOMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL GLIOBLASTOMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL GLIOBLASTOMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL MENINGIOMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL MENINGIOMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL MENINGIOMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL METASTATIC TUMORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL METASTATIC TUMORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL METASTATIC TUMORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CHRONIC PAIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL CHRONIC PAIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL CHRONIC PAIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL SCIATICA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL SCIATICA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL SCIATICA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL TRIGEMINAL NEURALGIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL TRIGEMINAL NEURALGIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL TRIGEMINAL NEURALGIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL EPILEPSY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL EPILEPSY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL EPILEPSY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL FOCAL EPILEPSY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL FOCAL EPILEPSY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL FOCAL EPILEPSY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL TEMPORAL LOBE EPILEPSY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL TEMPORAL LOBE EPILEPSY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL TEMPORAL LOBE EPILEPSY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL MOVEMENT DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL MOVEMENT DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL MOVEMENT DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL DYSTONIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL DYSTONIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL DYSTONIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL ESSENTIAL TREMOR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL ESSENTIAL TREMOR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL ESSENTIAL TREMOR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL PARKINSON’S DISEASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL PARKINSON’S DISEASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 76. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 77. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 78. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 79. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 80. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 81. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 82. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 83. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 85. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 86. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 87. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 88. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 89. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 90. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 91. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 92. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 94. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 95. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 96. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 97. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 98. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 99. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 100. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 101. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 103. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 104. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 105. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 106. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 107. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 108. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 109. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 110. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 112. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 113. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 114. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 115. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 116. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 117. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 118. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 119. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 120. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 121. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 122. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 123. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 124. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 125. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 126. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 127. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 129. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 130. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 131. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 132. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 133. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 134. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 135. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 136. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 137. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 138. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 139. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 140. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 141. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 142. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 143. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 144. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 145. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 146. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 147. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 148. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 149. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 150. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 151. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 152. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 153. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 154. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 155. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 162. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 165. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 166. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 167. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 168. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 169. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 170. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 171. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 172. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 173. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 174. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 175. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 176. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 177. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 178. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 179. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 180. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 181. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 182. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 183. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 184. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 185. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 186. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 187. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 188. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 189. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 190. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 191. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 192. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 193. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 194. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 195. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 196. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 197. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 198. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 199. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 200. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 201. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 202. JAPAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 203. JAPAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 204. JAPAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 205. JAPAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 206. JAPAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 207. JAPAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 208. JAPAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 209. JAPAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 210. JAPAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 211. INDIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 212. INDIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 213. INDIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 214. INDIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 215. INDIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 216. INDIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 217. INDIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 218. INDIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 219. INDIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 220. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 221. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 222. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 223. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 224. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 225. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 226. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 227. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 228. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 229. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 230. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 231. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 232. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 233. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 234. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 235. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 236. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 237. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 238. AUSTRALIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 239. AUSTRALIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 240. AUSTRALIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 241. AUSTRALIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 242. AUSTRALIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 243. AUSTRALIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 244. AUSTRALIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 245. AUSTRALIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 246. AUSTRALIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 247. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 248. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 249. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 250. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 251. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 252. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 253. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 254. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 255. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 256. SOUTH KOREA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 257. SOUTH KOREA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 258. SOUTH KOREA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 259. SOUTH KOREA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 260. SOUTH KOREA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 261. SOUTH KOREA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 262. SOUTH KOREA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 263. SOUTH KOREA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 264. SOUTH KOREA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 265. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 266. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 267. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 268. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 269. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 270. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 271. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 272. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 273. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 274. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 275. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 276. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 277. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 278. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 279. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 280. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 281. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 282. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 283. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 284. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 285. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 286. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 287. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 288. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 289. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 290. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 291. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 292. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 293. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 294. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 295. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 296. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 297. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 298. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 299. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 300. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 301. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 302. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 303. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 304. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 305. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 306. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 307. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 308. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 309. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 310. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 311. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 312. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 313. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PROCEDURE OBJECTIVE, 2017-2032 (USD MILLION)
TABLE 314. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 315. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2017-2032 (USD MILLION)
TABLE 316. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2017-2032 (USD MILLION)
TABLE 317. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2017-2032 (USD MILLION)
TABLE 318. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2017-2032 (USD MILLION)
TABLE 319. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SHARE, BY KEY PLAYER, 2025
TABLE 320. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET, FPNV POSITIONI

Companies Mentioned

  • Accuray Incorporated
  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • ClearPoint Neuro, Inc.
  • Elekta AB
  • Insightec Ltd.
  • Medtronic plc
  • Monteris Medical Inc.
  • Profound Medical Corp.
  • Siemens Healthineers AG

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 785.53 Million
Forecasted Market Value ( USD ) by 2032 $ 1260 Million
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

MRI-Guided Neurosurgical Ablation - Global Strategic Business Report - Product Image

MRI-Guided Neurosurgical Ablation - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
MRI Guided Neurosurgical Ablation Market Outlook 2026-2034: Market Share and Growth Analysis by Product Type, Application, End User - Product Image

MRI Guided Neurosurgical Ablation Market Outlook 2026-2034: Market Share and Growth Analysis by Product Type, Application, End User

  • Report
  • 160 Pages
  • Global
From
Stereotactic System for Neurological Intervention Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type - Product Image

Stereotactic System for Neurological Intervention Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 94 Pages
  • Global
From
Magnetic Resonance Imaging (MRI) Guided and Focused Ultrasound Devices Market Report 2026 - Product Image

Magnetic Resonance Imaging (MRI) Guided and Focused Ultrasound Devices Market Report 2026

  • Report
  • 250 Pages
  • Global
From
MRI Guided Neurosurgery Market - A Global and Regional Analysis: Focus on Type, Product, Application, End User, Country, and Region - Analysis and Forecast, 2025-2035 - Product Image

MRI Guided Neurosurgery Market - A Global and Regional Analysis: Focus on Type, Product, Application, End User, Country, and Region - Analysis and Forecast, 2025-2035

  • Report
  • 120 Pages
  • Global
From

About the MRI Guided Neurosurgical Ablation Market

MRI Guided Neurosurgical Ablation is a minimally invasive procedure used to treat neurological disorders. It involves the use of MRI imaging to guide the placement of a probe into the brain, which then delivers energy to the targeted area to destroy or ablate the tissue. This procedure is used to treat a variety of neurological conditions, including epilepsy, Parkinson's disease, and brain tumors. It is also used to treat chronic pain and other neurological disorders. MRI Guided Neurosurgical Ablation is a relatively new procedure, but it is becoming increasingly popular due to its minimally invasive nature and its ability to provide precise targeting of the affected area. It is also less expensive than traditional open surgery and has fewer risks associated with it. Some of the companies in the MRI Guided Neurosurgical Ablation market include Medtronic, Stryker, Brainlab, and Elekta. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.